US Patent Issued to Gilead Sciences on Sept. 23 for "Bridged tricyclic carbamoylpyridone compounds and uses thereof" (California Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,235, issued on Sept. 23, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Bridged tricyclic carbamoylpyridone compounds and uses thereof" was invented by Hang Chu (San Mateo, Calif.), Hongyan Guo (San Mateo, Calif.), Lan Jiang (Foster City, Calif.), Jiayao Li (Foster City, Calif.), David W. Lin (Berkeley, Calif.), Hyung-Jung Pyun (Fremont, Calif.), Qiaoyin Wu (Foster City, Calif.), Hong Yang (Fremont, Calif.), Adam D. Zajdlik (San Francisco) and Jennifer R. Zhang (Union City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The c...